ATE534907T1 - Verfahren für den nachweis von l523s-expression in biologischen proben - Google Patents
Verfahren für den nachweis von l523s-expression in biologischen probenInfo
- Publication number
- ATE534907T1 ATE534907T1 AT08075577T AT08075577T ATE534907T1 AT E534907 T1 ATE534907 T1 AT E534907T1 AT 08075577 T AT08075577 T AT 08075577T AT 08075577 T AT08075577 T AT 08075577T AT E534907 T1 ATE534907 T1 AT E534907T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- cells
- antibody
- biological samples
- expression
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57476—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncofetal proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75183305P | 2005-12-20 | 2005-12-20 | |
US77321206P | 2006-02-14 | 2006-02-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE534907T1 true ATE534907T1 (de) | 2011-12-15 |
Family
ID=37903564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08075577T ATE534907T1 (de) | 2005-12-20 | 2006-12-20 | Verfahren für den nachweis von l523s-expression in biologischen proben |
Country Status (4)
Country | Link |
---|---|
US (3) | US20090053731A1 (de) |
EP (2) | EP2407787B1 (de) |
AT (1) | ATE534907T1 (de) |
WO (1) | WO2007071250A2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080242606A1 (en) * | 2006-06-06 | 2008-10-02 | Zhong Jiang | Use of IMP3 as a Prognostic Marker for Cancer |
US20100211066A1 (en) * | 2006-06-06 | 2010-08-19 | University Of Massachusetts | Use of IMP3 as a Prognostic Marker for Cancer |
US10983119B2 (en) * | 2016-01-25 | 2021-04-20 | General Electric Company | Device for rapid diagnostic tests to detect antigens with improved sensitivity |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4275149A (en) * | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4318980A (en) * | 1978-04-10 | 1982-03-09 | Miles Laboratories, Inc. | Heterogenous specific binding assay employing a cycling reactant as label |
US4737456A (en) * | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
DK130991D0 (da) * | 1991-07-04 | 1991-07-04 | Immunodex K S | Polymere konjugater |
US6531315B1 (en) * | 1998-03-18 | 2003-03-11 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US7579160B2 (en) * | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
US7049063B2 (en) * | 1998-03-18 | 2006-05-23 | Corixa Corporation | Methods for diagnosis of lung cancer |
US20020147143A1 (en) * | 1998-03-18 | 2002-10-10 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6696247B2 (en) * | 1998-03-18 | 2004-02-24 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6518256B1 (en) * | 1998-03-18 | 2003-02-11 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US20030236209A1 (en) * | 1998-03-18 | 2003-12-25 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US20020115139A1 (en) * | 2000-12-12 | 2002-08-22 | Kalos Michael D. | Compositions and methods for the therapy and diagnosis of lung cancer |
US20030138438A1 (en) * | 1998-03-18 | 2003-07-24 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6482597B1 (en) * | 1999-12-17 | 2002-11-19 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US6297364B1 (en) * | 1998-04-17 | 2001-10-02 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
US7666609B1 (en) * | 1998-12-01 | 2010-02-23 | Shanghai Cp Guojian Pharmaceutical Co. Ltd. | Method and composition for diagnosis of melanocytic lesions |
US6969518B2 (en) * | 1998-12-28 | 2005-11-29 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US6960750B2 (en) * | 2003-01-08 | 2005-11-01 | The Boeing Company | Optical positioning system and method, transceiver, and reflector |
-
2006
- 2006-12-20 EP EP11075221A patent/EP2407787B1/de active Active
- 2006-12-20 EP EP08075577A patent/EP2163898B1/de active Active
- 2006-12-20 WO PCT/DK2006/000732 patent/WO2007071250A2/en active Application Filing
- 2006-12-20 US US12/158,223 patent/US20090053731A1/en not_active Abandoned
- 2006-12-20 AT AT08075577T patent/ATE534907T1/de active
-
2014
- 2014-09-22 US US14/492,171 patent/US9869678B2/en active Active
-
2017
- 2017-11-30 US US15/828,017 patent/US20180080936A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20180080936A1 (en) | 2018-03-22 |
EP2407787A2 (de) | 2012-01-18 |
WO2007071250A3 (en) | 2007-09-20 |
WO2007071250A2 (en) | 2007-06-28 |
US20090053731A1 (en) | 2009-02-26 |
US20150072891A1 (en) | 2015-03-12 |
EP2407787A3 (de) | 2012-02-15 |
EP2163898A1 (de) | 2010-03-17 |
EP2407787B1 (de) | 2013-03-27 |
US9869678B2 (en) | 2018-01-16 |
EP2163898B1 (de) | 2011-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60041839D1 (de) | Auto-Antikörper gegen Annexin-Proteine als Marker für Lungenkrebs | |
ATE428931T1 (de) | Verfahren zur durchführung von vollbluttests | |
DE602005026273D1 (de) | Vorrichtungen und verfahren für abnahme, lagerung und transport von biologischen proben | |
ATE541054T1 (de) | Bio-barcode erkennung für zielmoleküle | |
ATE540319T1 (de) | Verfahren für die bestimmung von fk506 | |
ATE520026T1 (de) | Sequenzielle analyse biologischer proben | |
ATE432947T1 (de) | Menschliche antikörper als detektionsreagenzien | |
DE602005014835D1 (de) | Methode, Apparat, Reagenzkit und Reagenz zur Unterscheidung von Erythrozyten in biologischen Proben | |
WO2004011607A3 (en) | Reagent and method for determination of a substance using an immunoaggregator | |
ATE554106T1 (de) | Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung | |
EA201390638A8 (ru) | Обогащение и идентификация фетальных клеток в материнской крови и лиганды для такого применения | |
ATE462803T1 (de) | Kit und verfahren zum nachweis von urothelkarzinom | |
DE602007007775D1 (de) | Reagenz für hämoglobinabbau | |
DE60325107D1 (de) | Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe | |
ATE504833T1 (de) | Verfahren zur bestimmung des phänotyps von zellen | |
ATE529533T1 (de) | Verfahren zum nachweis von analyten in einer probe | |
RU2011140006A (ru) | Способ детекции вещества в биологическом образце | |
DE60029413D1 (de) | Enzymatische messung von mycophenolsäure | |
ATE534907T1 (de) | Verfahren für den nachweis von l523s-expression in biologischen proben | |
DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
ATE449341T1 (de) | Verfahren zur quantifizierung einer bestimmten zellpopulation in einer menschlichen blutprobe | |
SE0602683L (sv) | Diagnostisk metod | |
ATE437372T1 (de) | Verfahren zur messung von proinsulin und c-peptid sowie kit dafür | |
ATE459000T1 (de) | Verfahren für den nachweis von gad65 selbstreaktiven t-zellen | |
DE602004011228D1 (de) | Verfahren und zusammensetzungen zur bestimmung glycierter proteine |